United Kingdom Diabetes Care Devices Market Outlook to 2025 – Glucose Monitoring and Insulin Delivery

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “United Kingdom Diabetes Care Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United Kingdom Diabetes Care Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Glucose Monitoring and Insulin Delivery.

The United Kingdom Diabetes Care Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Diabetes Care Devices Market.
• Global corporate-level profiles of key companies operating within the United Kingdom Diabetes Care Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Diabetes Care Devices is segmented as follows:

• Glucose Monitoring and Insulin Delivery

Reasons to Buy

Key Reasons to Purchase – The United Kingdom Diabetes Care Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United Kingdom Diabetes Care Devices Market Outlook to 2025” report:
• DexCom Inc
• Medtronic Plc
• Abbott Laboratories

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Diabetes Care Devices Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Diabetes Care Devices Market, United Kingdom 10

3.1 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2025 10

3.2 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2019 12

3.3 Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2019 13

3.4 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2025 14

3.5 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025 16

3.6 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025 18

3.7 Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), 2019 20

4 Glucose Monitoring Market, United Kingdom 22

4.1 Glucose Monitoring Market, United Kingdom, Revenue ($m), 2015-2025 22

4.1.1 Blood Glucose Meters Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 24

4.2 Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2025 26

4.2.1 Blood Glucose Meters Market, United Kingdom, Volume (Units), by Segment, 2015-2025 28

4.3 Glucose Monitoring Market, United Kingdom, Average Price ($) , 2015-2025 30

4.4 Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), 2019 31

4.5 Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), 2019 32

5 Insulin Delivery Market, United Kingdom 33

5.1 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2019 33

5.2 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2019 34

5.3 Insulin Delivery Market, United Kingdom, Revenue ($m), 2015-2025 35

5.3.1 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 37

5.3.2 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 39

5.4 Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2025 41

5.4.1 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2015-2025 43

5.4.2 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2015-2025 45

5.5 Insulin Delivery Market, United Kingdom, Average Price ($), 2015-2025 47

5.6 Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), 2019 48

5.7 Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), 2019 49

6 Overview of Key Companies in United Kingdom, Diabetes Care Devices Market 51

6.1 DexCom Inc 51

6.1.1 Company Overview 51

6.2 Medtronic Plc 51

6.2.1 Company Overview 51

6.3 Abbott Laboratories 51

6.3.1 Company Overview 51

6.4 Novo Nordisk AS 52

6.4.1 Company Overview 52

6.5 Sanofi 52

6.5.1 Company Overview 52

6.6 Eli Lilly and Co 52

6.6.1 Company Overview 52

6.7 Ypsomed Holding AG 53

6.7.1 Company Overview 53

6.8 F. Hoffmann-La Roche Ltd 53

6.8.1 Company Overview 53

7 Diabetes Care Devices Market Pipeline Products 54

8 Financial Deals Landscape 55

8.1 Equity Offerings 55

8.1.1 Midatech Pharma Raises USD3 Million in Private Placement of American Depositary Shares 55

8.1.2 Nemaura Medical to Raise up to USD19.5 Million in Public Offering of Shares 57

8.2 Partnerships 58

8.2.1 LifeScan Enters into Distribution Agreement with Sanvita Medical 58

8.2.2 Diabeloop and ViCentra Enter into Distribution Agreement 59

9 Recent Developments 60

9.1 Corporate Communications 60

9.1.1 Feb 27, 2020: ConvaTec Group: Non-executive director appointment 60

9.1.2 Dec 18, 2019: Pfizer and Mylan announce two future Viatris board members 60

9.1.3 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 61

9.1.4 Sep 09, 2019: Midatech Pharma announces directorate change 61

9.1.5 Aug 19, 2019: AstraZeneca appoints Michel Demaré to its board of directors 62

9.1.6 Aug 19, 2019: John McAdam appointed Chairman of ConvaTec 63

9.1.7 Jul 31, 2019: Midatech Pharma: Appointment of Non-Executive Director 63

9.1.8 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 64

9.1.9 Jun 25, 2019: ConvaTec Group: Board Change 65

9.2 Financial Announcements 65

9.2.1 Feb 28, 2020: ConvaTec Group: Audited annual results for the twelve months ended 31 December 2019 65

9.2.2 Feb 14, 2020: AstraZeneca: Full-year and Q4 2019 results 66

9.2.3 Feb 11, 2020: Nemaura Medical reports results and provides business update for the third quarter ended December 31, 2019 69

9.2.4 Nov 11, 2019: Nemaura medical reports results and provides business update for the second quarter ended september 30, 2019 70

9.2.5 Oct 24, 2019: AstraZeneca: Year-to-date and Q3 2019 results 70

9.2.6 Sep 30, 2019: Midatech Pharma: Interim results for the six months ended 30 June 2019 74

9.2.7 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report 79

9.2.8 Aug 09, 2019: Nemaura Medical reports quarterly results for first quarter ended June 30, 2019 79

9.2.9 Aug 01, 2019: ConvaTec Group first half results 2019 80

9.2.10 Jul 25, 2019: AstraZeneca announces H1 2019 results 87

9.2.11 Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update 93

9.2.12 Apr 26, 2019: AstraZeneca: Q1 2019 results 95

9.2.13 Apr 24, 2019: Midatech Pharma: Audited financial results for the year ended 31 December 2018 97

9.3 Government and Public Interest 98

9.3.1 Nov 28, 2019: Sosei Heptares announces that the COPD treatment Ultibro Breezhaler has been included in the national reimbursement drug list in China 98

9.3.2 May 21, 2019: DiaMedica Therapeutics announces formation of scientific advisory board for kidney disease 100

9.4 Legal And Regulatory 102

9.4.1 Nov 12, 2019: OGT continues move into molecular diagnostics markets 102

9.4.2 Jun 11, 2019: Regulators demand more details on Roche’s $4.8bn Spark acquisition 102

9.5 Other Significant Developments 103

9.5.1 Oct 21, 2019: CRISPR Therapeutics and Bayer announce an update on Casebia Therapeutics 103

9.5.2 Jul 29, 2019: OBN announce Thermo Fisher Scientific as a new Corporate Sponsor 103

9.5.3 Jul 15, 2019: EKF Diagnostics Holdings: Trading update 103

9.5.4 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility 104

9.5.5 May 09, 2019: Cellnovo announces the initiation of compulsory liquidation proceedings with cessation of business 104

9.6 Product News 104

9.6.1 Jan 13, 2020: Artificial Intelligence (AI) can detect low-glucose levels via ECG without fingerpick test 104

9.7 Strategy And Business Planning 105

9.7.1 Dec 17, 2019: Roche gets UK and US clearances for Spark Therapeutics acquisition 105

9.7.2 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 106

9.7.3 Nov 12, 2019: Mylan and Pfizer announce Viatris as the new company name in the planned Mylan-Upjohn combination 107

10 Appendix 108

10.1 Research Methodology 109

10.1.1 Coverage 109

10.1.2 Secondary Research 109

10.1.3 Primary Research 110

10.1.4 Market Modeling and Forecasting 110

10.1.5 Company Share Analysis 112

10.1.6 Distribution Share Analysis 112

10.1.7 Benchmarking 113

10.2 GlobalData Consulting 113

10.3 Contact Us 114

10.4 Disclaimer 114

Table

1.1 List of Tables

Table 1: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 11

Table 2: Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2019 13

Table 3: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2015-2020 15

Table 4: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2021-2025 15

Table 5: Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025 17

Table 6: Diabetes Care Devices Market, United Kingdom, Volume (Units), Historic, 2015-2020 19

Table 7: Diabetes Care Devices Market, United Kingdom, Volume (Units), Forecast, 2021-2025 19

Table 8: Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2019 21

Table 9: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 23

Table 10: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 23

Table 11: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 25

Table 12: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 25

Table 13: Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2020 27

Table 14: Glucose Monitoring Market, United Kingdom, Volume (Units), 2021-2025 27

Table 15: Blood Glucose Meters Market, United Kingdom, Volume (Units), 2015-2020 29

Table 16: Blood Glucose Meters Market, United Kingdom, Volume (Units), 2021-2025 29

Table 17: Glucose Monitoring Market, United Kingdom, Average Price ($), 2015-2020 30

Table 18: Glucose Monitoring Market, United Kingdom, Average Price ($), 2021-2025 30

Table 19: Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2019 31

Table 20: Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2019 32

Table 21: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2019 34

Table 22: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 36

Table 23: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 36

Table 24: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 38

Table 25: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 38

Table 26: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 40

Table 27: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 40

Table 28: Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2020 42

Table 29: Insulin Delivery Market, United Kingdom, Volume (Units), 2021-2025 42

Table 30: Insulin Pens Market, United Kingdom, Volume (Units), 2015-2020 44

Table 31: Insulin Pens Market, United Kingdom, Volume (Units), 2021-2025 44

Table 32: Insulin Pumps Market, United Kingdom, Volume (Units), 2015-2020 46

Table 33: Insulin Pumps Market, United Kingdom, Volume (Units), 2021-2025 46

Table 34: Insulin Delivery Market, United Kingdom, Average Price ($), 2015-2020 47

Table 35: Insulin Delivery Market, United Kingdom, Average Price ($), 2021-2025 47

Table 36: Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2019 48

Table 37: Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2019 50

Table 38: Diabetes Care Devices Market Pipeline Products 54

Table 39: Midatech Pharma Raises USD3 Million in Private Placement of American Depositary Shares 55

Table 40: Nemaura Medical to Raise up to USD19.5 Million in Public Offering of Shares 57

Table 41: LifeScan Enters into Distribution Agreement with Sanvita Medical 58

Table 42: Diabeloop and ViCentra Enter into Distribution Agreement 59

Figures

1.2 List of Figures

Figure 1: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 10

Figure 2: Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2019 12

Figure 3: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2019 13

Figure 4: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2015-2025 14

Figure 5: Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025 16

Figure 6: Diabetes Care Devices Market, United Kingdom, Volume (Units), Historic, 2015-2025 18

Figure 7: Diabetes Care Devices Market, United Kingdom, Company Share (%) 2019 20

Figure 8: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 22

Figure 9: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 24

Figure 10: Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2025 26

Figure 11: Blood Glucose Meters Market, United Kingdom, Volume (Units), 2015-2025 28

Figure 12: Glucose Monitoring Market, United Kingdom, Company Share (%) 2019 32

Figure 13: Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2019 33

Figure 14: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2019 34

Figure 15: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 35

Figure 16: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 37

Figure 17: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 39

Figure 18: Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2025 41

Figure 19: Insulin Pens Market, United Kingdom, Volume (Units), 2015-2025 43

Figure 20: Insulin Pumps Market, United Kingdom, Volume (Units), 2015-2025 45

Figure 21: Insulin Delivery Market, United Kingdom, Company Share (%) 2019 49

Frequently asked questions

United Kingdom Diabetes Care Devices Market Outlook to 2025 – Glucose Monitoring and Insulin Delivery thematic reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United Kingdom Diabetes Care Devices Market Outlook to 2025 – Glucose Monitoring and Insulin Delivery in real time.

  • Access a live United Kingdom Diabetes Care Devices Market Outlook to 2025 – Glucose Monitoring and Insulin Delivery dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.